Author Question: When administering nose drops, the bulb of the dropper should be slanted: a. toward the client's ... (Read 79 times)

Pineappleeh

  • Hero Member
  • *****
  • Posts: 585
When administering nose drops, the bulb of the dropper should be slanted:
 
  a. toward the client's jaw.
  b. toward the client's nose.
  c. in the most comfortable manner for the nurse and client.
  d. in the most comfortable manner for the client.

Question 2

The nurse understands which of the following drugs should not be used to treat nasal congestion in a 5-year-old client?
 
  a. oxymetazoline HCl c. pseudoephedrine HCl
  b. chlorpheniramine d. meclizine HCl



Anonymous

  • Sr. Member
  • ****
  • Posts: 317
Answer to Question 1

ANS: A

Feedback
A Correct: This is the correct technique.
B Incorrect: This is not the correct technique.
C Incorrect: This is not a basis for positioning the client for administering nasal drops.
D Incorrect: This is not a basis for positioning the client for administering nasal drops.

Answer to Question 2

ANS: D

Feedback
A Incorrect: This is safe in children 2-6 years of age and up.
B Incorrect: This is safe for children 2-5 years of age and up.
C Incorrect: This is safe for children 2-5 years of age and up.
D Correct: This is not approved for use in children under the age of 12.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Medication errors are more common among seriously ill patients than with those with minor conditions.

Did you know?

To maintain good kidney function, you should drink at least 3 quarts of water daily. Water dilutes urine and helps prevent concentrations of salts and minerals that can lead to kidney stone formation. Chronic dehydration is a major contributor to the development of kidney stones.

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library